Glucose-6-phosphate dehydrogenase deficiency secondary prevention: Difference between revisions
No edit summary |
No edit summary |
||
Line 16: | Line 16: | ||
Effective measures for the secondary prevention of G6PD deficiency include: | Effective measures for the secondary prevention of G6PD deficiency include: | ||
* Avoiding triggers ( some foods and drugs) | * Avoiding triggers ( some foods and drugs)[[Glucose-6-phosphate dehydrogenase deficiency primary prevention#cite note-pmid27040960-1|[1]]] | ||
==References== | ==References== |
Revision as of 19:56, 24 August 2018
Glucose-6-phosphate dehydrogenase deficiency Microchapters |
Differentiating Glucose-6-phosphate dehydrogenase deficiency from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Glucose-6-phosphate dehydrogenase deficiency secondary prevention On the Web |
American Roentgen Ray Society Images of Glucose-6-phosphate dehydrogenase deficiency secondary prevention |
FDA on Glucose-6-phosphate dehydrogenase deficiency secondary prevention |
CDC on Glucose-6-phosphate dehydrogenase deficiency secondary prevention |
Glucose-6-phosphate dehydrogenase deficiency secondary prevention in the news |
Blogs on Glucose-6-phosphate dehydrogenase deficiency secondary prevention |
Directions to Hospitals Treating Glucose-6-phosphate dehydrogenase deficiency |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mahda Alihashemi M.D. [2]
Overview
There are no established measures for the secondary prevention of [disease name].
OR
Effective measures for the secondary prevention of [disease name] include [strategy 1], [strategy 2], and [strategy 3].
Secondary Prevention
There are no established measures for the secondary prevention of [disease name].
OR
Effective measures for the secondary prevention of G6PD deficiency include:
- Avoiding triggers ( some foods and drugs)[1]
References
Glucose-6-phosphate dehydrogenase deficiency Microchapters |
Differentiating Glucose-6-phosphate dehydrogenase deficiency from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Glucose-6-phosphate dehydrogenase deficiency secondary prevention On the Web |
American Roentgen Ray Society Images of Glucose-6-phosphate dehydrogenase deficiency secondary prevention |
FDA on Glucose-6-phosphate dehydrogenase deficiency secondary prevention |
CDC on Glucose-6-phosphate dehydrogenase deficiency secondary prevention |
Glucose-6-phosphate dehydrogenase deficiency secondary prevention in the news |
Blogs on Glucose-6-phosphate dehydrogenase deficiency secondary prevention |
Directions to Hospitals Treating Glucose-6-phosphate dehydrogenase deficiency |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [3]; Associate Editor(s)-In-Chief: Priyamvada Singh, M.D. [4]
Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.
Overview
Glucose-6-phosphate dehydrogenase (G6PD) deficiency is an X-linked recessive hereditary disease featuring abnormally low levels of the G6PD enzyme, which plays an important role in red blood cell function. Individuals with the disease may exhibit non-immune hemolytic anemia in response to a number of causes. It is closely linked to favism, a disorder characterized by a hemolytic reaction to consumption of broad beans, with a name derived from the Italian name of the broad bean (fava). Sometimes the name, favism, is alternatively used to refer to the enzyme deficiency as a whole.